Kuur is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies.
Our approach combines the highly differentiated, natural biology of a specific subset of T cells, called natural killer T cells (NKT cells) and innovative chimeric antigen receptor (CAR) construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors.
Company Details
- Employees
- 8
- Address
- 2617 Bissonnet St,
- Phone
- 44 20 7554 4070
- in****@****rtx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- kuurtx.com
- Keywords
- Immunotherapy, Cancer, Oncology, T cells, TCR, CAR, CAR-NKT, clinical trial, NKT Cells, celltherapy, lifesciences.
- HQ
- Houston, Texas
Kuur Therapeutics Questions
Kuur Therapeutics's helpline number is 44 20 7554 4070
Kuur Therapeutics's website is kuurtx.com
Kuur Therapeutics's LinkedIn profile is https://www.linkedin.com/company/kuurtx
Kuur Therapeutics has
8 employees.
View email and phone details for 8
employees at Kuur Therapeutics.
Kuur Therapeutics's industry is
Biotechnology Research
Kuur Therapeutics's top competitors are
Athenex,
Fate Therapeutics Inc.,
Tango Therapeutics,
Alaunos Therapeutics,
Eureka Therapeutics, Inc,
Neon Therapeutics,
Avenacy,
Quell Therapeutics,
Autolus Therapeutics,
Achilles Therapeutics Plc.
Kuur Therapeutics's support email address is info@kuurtx.com
Kuur Therapeutics's categories are Biotechnology Research
